Jacobs Levy Equity Management’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,423	Closed	-$239K	–	1015
2022 Q2	$239K	Hold	6,423	–	–	﹤0.01%	947
2022 Q1	$284K	Sell	6,423 -2,056	-24%	-$89.1K	﹤0.01%	929
2021 Q4	$360K	Sell	8,479 -73,928	-90%	-$3.11M	﹤0.01%	878
2021 Q3	$3.58M	Buy	+82,407	New	+$3.65M	0.02%	500
2018 Q1	–	Sell	-18,810	Closed	-$466K	–	1004
2017 Q4	$466K	Buy	+18,810	New	+$519K	0.01%	767
2016 Q2	–	Sell	-107,030	Closed	-$2.01M	–	1162
2016 Q1	$2.01M	Sell	107,030 -692,870	-87%	-$12.2M	0.04%	408
2015 Q4	$14.8M	Buy	799,900 +84,200	+12%	+$1.51M	0.29%	112
2015 Q3	$11.7M	Sell	715,700 -195,230	-21%	-$3.34M	0.24%	128
2015 Q2	$16.1M	Sell	910,930 -87,600	-9%	-$1.57M	0.31%	112
2015 Q1	$17.7M	Sell	998,530 -823,958	-45%	-$13M	0.3%	114
2014 Q4	$24.1M	Buy	1,822,488 +458,560	+34%	+$5.86M	0.41%	71
2014 Q3	$16.1M	Sell	1,363,928 -4,200	-0.3%	-$52.9K	0.27%	123
2014 Q2	$17.5M	Buy	+1,368,128	New	+$17.8M	0.29%	112
2014 Q1	–	Sell	-12,230	Closed	-$147K	–	897
2013 Q4	$147K	Buy	+12,230	New	+$144K	﹤0.01%	887
2013 Q3	–	Sell	-1,129,900	Closed	-$10.5M	–	931
2013 Q2	$10.5M	Buy	+1,129,900	New	+$9.58M	0.19%	161